Fair warning: We’re really not sure what’s going on here.
The authors of “Effect of total flavonoids on expression of collagen, TGF-β1, and Smad 7 in hypertrophic scars,” a 2018 paper in the International Journal of Clinical and Experimental Medicine, have retracted it for, well, lots of reasons.
In early 2011, less than six months after we launched Retraction Watch, we came across a retraction from a surgery journal. The notice was scant on details, so co-founder Adam Marcus called the editor to ask why the paper had been retracted.
It turns out that’s still the answer from some journal editors. In a recent paper, Mark Bolland, of the University of Auckland, and colleagues — including one journalist — found that when they contacted a dozen journals that had published nearly two dozen clinical trials “about which concerns had been previously raised,” “none of the 10 responses was considered very useful.” (The trials were all co-authored by the late Yoshihiro Sato, who is now up to 42 retractions.)
Last month, the Journal of Pediatric Gastroenterology and Nutrition pulled an article on fecal transplantation for a reason that, well, doesn’t pass the sniff test.
The paper, by Sonia Michail of Children’s Hospital Los Angeles, appeared online in October 2017 and described a randomized controlled trial of fecal transplants to treat kids with ulcerative colitis. (If you’re interested, here’s an overview of how fecal transplantation works.) The trial, or one awfully like it, is listed on ClinicalTrials.gov, and shows Michail as the lone investigator on the study, which is aiming to gather more than 100 participants.
But the journal retracted the article — which was the subject of a laudatory editorial in the journal pointing readers to the findings — with an entirely opaque statement, saying that the work
The paper has been republished in the same journal, adding another chapter to Shaw and Tomljenovic’s confusing record of publishing and withdrawing papers. The journal did not respond to our request for comment, but Shaw told Retraction Watch:
The mistake occurred after the authors submitted revisions to the manuscript without tracking the changes, prompting the publisher to believe nothing had been changed and publishing the previous version. The journal initially told the authors it planned to publish an erratum that described the mistake as a production error, but then retracted the paper—seemingly without consulting the authors. However, the authors said they were happy with the outcome.
Here’s a head-scratcher: A 2017 paper examining why long space flights can cause eye damage has been taken down, with a brief note saying NASA, which sponsored the research, asked for the retraction because of “security concerns.”
According to the first author, the paper included information that could identify some of the astronauts that took part in the study — namely, their flight information. Although the author said he removed the identifying information after the paper was online, NASA still opted to retract it. But a spokesperson at NASA told us the agency did not supply the language for the retraction notice. The journal editor confirmed the paper was retracted for “research subject confidentiality issues,” but referred a question about who supplied the language of the notice back to NASA.
Now lawyers are involved.
So we still have some questions about this one. Here’s what we do know.
Two journals are retracting papers published by researchers affiliated with Children’s Hospital Los Angeles (CHLA).
To be frank, we’re baffled by most of this story. The retraction notices say “the institution” requested the retractions, but don’t name it; the first and last authors are also affiliated with the University of Southern California, as well as CHLA. Neither journal will say which institution sent the request, and USC and CHLA have each declined to comment on the retractions.
An exercise scientist who ran a study of the CrossFit exercise program without an approved human subjects protocol has lost two more papers to retraction.
Both papers were retracted on June 26 by the editors of the International Journal of Exercise Science (IJES) with the agreement of last author Steven Devor, a former professor at The Ohio State University. Both have been retracted because the studies were carried out without proper IRB approval.
Only one of the newly retracted papers had anything to do with the CrossFit study: Published in April 2014, this paper suggested that the so-called “paleo” diet — a diet focused on meat and vegetables — is associated with “unfavorable” changes in cholesterols and other blood-based cardiovascular biomarkers. In addition to following the diet, subjects also participated in a CrossFit exercise program.Continue reading Researcher who tangled with CrossFit loses two more papers
That happened this week, when we saw a retraction notice for a 2015 paper on gastric cancer in the International Journal of Clinical and Experimental Medicine, which only says the authors “made big mistakes” and contains two fairly significant typos.